CYTOSORBENTS CORPORATION - COMMON STOCK
0.9700
25-November-24 09:10:12
15 minutes delayed
Stocks
+0.0500
+5.43%
Today's range
0.9063 - 0.9700
ISIN
N/A
Source
NASDAQ
-
CytoSorbents to Present at the 8th Annual Dawson James Conference
05 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
27 Sep 2023 06:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents Announces Kathleen P. Bloch To Resume as Full-Time Chief Financial Officer
19 Sep 2023 06:00:00 By Nasdaq GlobeNewswire
-
CytoSorb with Ex Vivo Organ Perfusion: Transforming the Future of Solid Organ Transplantation
11 Sep 2023 10:32:17 By Nasdaq GlobeNewswire
-
CytoSorbents Announces Resignation of Chief Financial Officer Alexander D’Amico
01 Sep 2023 15:43:18 By Nasdaq GlobeNewswire
-
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
31 Aug 2023 06:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents Reports Second Quarter 2023 Financial and Operational Results
01 Aug 2023 15:15:01 By Nasdaq GlobeNewswire
-
CytoSorbents to Report Second Quarter 2023 Operating and Financial Results
26 Jul 2023 06:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents Appoints Alexander D’Amico as Chief Financial Officer
19 Jul 2023 06:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents And Humedics Announce Theranostic Collaboration in the Field of Liver Disease
11 Jul 2023 06:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents Completes Enrollment of the STAR-T Pivotal Trial
07 Jul 2023 06:07:00 By Nasdaq GlobeNewswire
-
15 Jun 2023 06:00:01 By Nasdaq GlobeNewswire
-
05 Jun 2023 08:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents Reports First Quarter 2023 Results
02 May 2023 15:15:00 By Nasdaq GlobeNewswire
-
CytoSorbents to Report First Quarter 2023 Operating and Financial Results
26 Apr 2023 06:00:00 By Nasdaq GlobeNewswire
-
CytoSorbents’ Pivotal STAR-T Trial Reaches Second Key Milestone With 80 Patients Enrolled
20 Apr 2023 06:00:01 By Nasdaq GlobeNewswire
-
CytoSorbents Announces Board Chairman Al W. Kraus To Retire
19 Apr 2023 06:00:00 By Nasdaq GlobeNewswire
-
29 Mar 2023 07:30:00 By Nasdaq GlobeNewswire
-
22 Mar 2023 07:09:06 By Nasdaq GlobeNewswire
-
CytoSorbents Comments on Bank Exposure and Diversified Cash Position
14 Mar 2023 06:00:00 By Nasdaq GlobeNewswire